Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Regorafenib Tablets

Approval Number

国药准字H20253676

Company北京双鹭药业股份有限公司

Registration Date

March 25, 2025

Drug Information

Generic Name

瑞戈非尼片

Dosage Form

片剂

Strength

40mg

Drug Type

化学药品

Registration Date

March 25, 2025

Company Information

Applicant Company

Company Name北京双鹭药业股份有限公司

Company Address

北京市海淀区阜石路69号碧桐园1号楼4层

Manufacturing Company

Company Name北京双鹭药业股份有限公司

Company Address

北京市大兴区中关村科技园区大兴生物医药产业基地华佗路32号院

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

瑞戈非尼片 - NMPA 批准文号 | MedPath